Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial.
Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, Van Dyck C, Galvin JE, Emond J, Jack CR Jr, Weiner M, et al. JAMA. 2010 Nov 3; 304(17):1903-11.